- About Us
- Participant Zone
The demand for Drugs of Abuse testing has risen rapidly over the years, especially in a Point of Care Setting due to a variety of Medical, Professional and Legal reasons. Weqas provides an ISO 17043 accredited Urine Drugs of Abuse programme suitable for Laboratory and Point of Care testing sites.
The programme will provide liquid stable samples that are commutable, stable and fit for intended purpose. We also provide education and training to understand the importance of evidence based quality assurance for minimising pre-analytical errors and reporting of erroneous test results.
Three liquid stable commutable samples are distributed bimonthly. The material is prepared from sterile urine from healthy donors, 3.0 mL volume supplied in sterile plastic tubes.
Samples per set: 3 x 3.0 mL samples
|Urine Drugs of Abuse Programme|
|Analyte||Approx. Range Covered|
|Amphetamine||0 - 3000||µg/L|
|Amphetamines Group Screen||Qualitative||n/a|
|Benzodiazepine||0 - 1000||µg/L|
|Barbiturate||0 - 1000||µg/L|
|Buprenorphine||0 - 50||µg/L|
|Cocaine||0 - 1000||µg/L|
|Cannabis||0 - 150||µg/L|
|EDDP||0 - 1000||µg/L|
|Heroin||0 - 50||µg/L|
|Ketamine||0 - 3000||µg/L|
|MDMA||0 - 3000||µg/L|
|Methadone||0 - 1000||µg/L|
|Methamphetamine (mAMP)||0 - 3000||µg/L|
|Opiate||0 - 3000||µg/L|
|Phencyclidine (PCP)||0 - 100||µg/L|
|Tricyclic antidepressants (TCA)||0 - 3000||µg/L|